Sign in

CIK 0001681682

  • Non-accelerated filer
  • Smaller reporting company

ENDRA Life Sciences Inc.

Sign in to watch
Ticker
NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
260579295
Phone
+1 734-335-0468
Business address
3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
Former names
Endra Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-04-05 Wells David R. Chief Financial Officer Grant or award · Stock Options +25,000 25,000
2021-01-06 Wells David R. Chief Financial Officer Sale −34,900 $0.90 $31K 80,003
2021-01-05 Wells David R. Chief Financial Officer Sale −100 $0.90 $90 114,903
2020-06-23 Wells David R. Chief Financial Officer Option exercise +5,000 $0.87 $4K 115,003
2020-06-23 Wells David R. Chief Financial Officer Option exercise · Warrants −5,000 5,051
2020-06-08 Wells David R. Chief Financial Officer Conversion +10,350 $0.87 $9K 110,003
2020-06-08 Wells David R. Chief Financial Officer Conversion · Series A Convertible Preferred Stock −8.74 $1,143.68 $10K 0
2020-04-09 Wells David R. Chief Financial Officer Grant or award +79,653 99,653
2020-01-25 Wells David R. Chief Financial Officer Grant or award · Stock Options +20,000 20,000
2019-12-11 Wells David R. Chief Financial Officer Grant or award · Stock option (right to buy) +138,375 138,375
2019-12-11 Wells David R. Chief Financial Officer Grant or award · Series A Convertible Preferred Stock +8.74 $1,143.68 $10K 8.74
2019-12-11 Wells David R. Chief Financial Officer Grant or award · Warrants +10,051 10,051
2019-09-27 Wells David R. Chief Financial Officer Purchase +10,000 $1.18 $12K 20,000
2019-08-23 Wells David R. Chief Financial Officer Purchase +5,000 $1.55 $8K 10,000
2019-08-22 Wells David R. Chief Financial Officer Purchase +5,000 $1.56 $8K 5,000
2019-05-13 Wells David R. Chief Financial Officer Grant or award · Stock Options +56,000 56,000
2018-12-13 Wells David R. Chief Financial Officer Grant or award · Stock Options +35,000 35,000
2018-11-13 Wells David R. Chief Financial Officer Conversion +5,953 $1.68 $10K 24,786
2018-11-13 Wells David R. Chief Financial Officer Conversion · Convertible Promissory Note −0 $10,000.00 $0
2018-06-28 Wells David R. Chief Financial Officer Grant or award · Convertible Promissory Note +0 $10,000.00 $0

Page 1 of 2 · 24 trades